Stay Informed on Key Developments

Investor News and Updates

Bill_Ipad

Stay informed about key developments at our company as they happen. Discover our Ad-Hoc Releases and subscribe to our newsletter to receive the latest news and topics of interest.

131 - 140of 392 News
131 - 140of 392 News
November 09, 2021
Third quarter of 2021:
Bayer grows sales and earnings significantly
READ MORE
November 09, 2021
Effective January 1, 2022:
Rodrigo Santos named member of the Board of Management, Bayer AG, and President of the Crop Science division
READ MORE
November 08, 2021
Not intended for U.S. and UK Media - The American Society of Nephrology (ASN)’s Kidney Week 2021:
New data from finerenone clinical trial program reinforces renal and cardiovascular benefits in patients with CKD and T2D independent of baseline therapy
READ MORE
November 05, 2021
Not intended for U.S. and UK Media - The American Heart Association Scientific Sessions 2021:
Bayer to present data from cardiovascular portfolio, including analyses from the comprehensive finerenone clinical trial program, VOYAGER PAD (Xarelto™) and the VICTORIA trial (Verquvo™)
READ MORE
October 29, 2021
Not intended for U.S. and UK Media
European Patent Office maintained Bayer patent on the once-daily administration of rivaroxaban (Xarelto™)
READ MORE
October 27, 2021
Not intended for U.S. and UK Media - The American Society of Nephrology (ASN)’s Kidney Week 2021:
Bayer to present new data from comprehensive finerenone clinical trial program
READ MORE
October 19, 2021
Bayer fuels leading market positions in Crop Science through delivery of unmatched innovation
READ MORE
September 20, 2021
Not intended for U.S. and UK Media
Bayer extends clinical development program for finerenone with Phase III study in patients with non-diabetic chronic kidney disease
READ MORE
September 16, 2021
Not intended for U.S. and UK Media - ESMO Congress 2021:
Latest analyses of Vitrakvi (larotrectinib) reaffirm powerful efficacy and tolerability profile for both adult and pediatric patients with TRK fusion cancer
READ MORE
September 09, 2021
Not intended for U.S. and UK Media
Bayer to highlight expanded research from growing oncology portfolio at ESMO Congress 2021
READ MORE
131 - 140of 392 News
131 - 140of 392 News
Inform Yourself on Special Topics
Control Weeds Not Farming

Control Weeds, Not Farming

LEARN MORE
Farmers discussing their weed management

Everything You Need to Know About Glyphosate

LEARN MORE
some-bayer-group-headquarters

Managing Glyphosate Litigation

learn more
woman harvesting carrots

Managing and Mitigating PCB Litigation Risk

learn more